Home / Companies / ImmunoGen, Inc. / 31 Jan 2024
ImmunoGen, Inc.: meeting of 31 Jan 2024
Votes reported on Form N-PX, item by item
431 Form N-PX filers reported votes at the ImmunoGen, Inc. meeting of 31 Jan 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
601 vote records from 415 filers. 295 of the 396 filers that marked the item either way voted against management. 19 filers reported this item without a management mark.
2 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on pay tied to a merger or sale
10 vote records from 9 filers. 4 of the 9 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
216 vote records from 112 filers. 1 of the 112 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
292 vote records from 136 filers. 14 of the 136 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Say-on-pay | 2. Merger pay |
|---|---|---|
| Vanguard | Against * | No report |
| BlackRock and iShares | Against * | No report |
| Fidelity | Against * | No report |
| Dimensional | Against * | No report |
| State Street and SPDR | Against * | No report |
| American Century | Against * | No report |
| Franklin Templeton | Abstain or withhold * | No report |
| Invesco | Against * | No report |
| Equitable | Against * | No report |
| Charles Schwab | Against * | No report |
| Nuveen and TIAA | Against * | No report |
| ProShares and ProFunds | Against * | No report |
| John Hancock and Manulife | Against * | No report |
| Morgan Stanley, Eaton Vance and Calvert | Against * | No report |
| J.P. Morgan | Against * | Against * |
| Goldman Sachs | Against * | No report |
| PGIM and Prudential | For | No report |
| Jackson National funds | Against * | No report |
| Northern Trust and FlexShares | Against * | No report |
| SEI | Against * | No report |
| T. Rowe Price | Against * | No report |
| Lincoln Financial | Against * | No report |
| Voya | Abstain or withhold * | No report |
| First Trust | Against * | No report |
| Nationwide | Against * | No report |
| Victory Capital | Against * | No report |
| Brighthouse Funds | Against * | No report |
| Guggenheim and Rydex | Against * | No report |
| Columbia Threadneedle | Against * | No report |
| BNY Mellon | Against * | No report |
| Principal | Against * | No report |
| Pacific Life funds | Against * | No report |
| Global X | Against * | No report |
| Transamerica | Against * | No report |
| AllianceBernstein | Against * | No report |
| Hartford Funds | Against * | No report |
| DWS | Against * | No report |
| PIMCO | Against * | No report |
| MassMutual | Against * | No report |
| Virtus | For | No report |
| Janus Henderson | Abstain or withhold * | No report |
| Neuberger Berman | For | No report |
| Natixis and Loomis Sayles | Against * | No report |
| Lord Abbett | Against * | No report |
| Baird | Against * | No report |
| Artisan Partners | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the ImmunoGen, Inc. meeting?
431 Form N-PX filers reported votes at the meeting of 31 Jan 2024. On say-on-pay, 295 of 396 voted against management (74.5%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by ImmunoGen, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for ImmunoGen, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing ImmunoGen, Inc. with a meeting date within three days of 31 Jan 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.